Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
CARENFERPA
1 other identifier
interventional
888
1 country
16
Brief Summary
Iron deficiency is defined by insufficient tissue iron stores and anemia is the ultimate stage of iron deficiency. Anemia should never be neglected in an elderly subject because it is associated with an increase in mortality, but also with a increased morbidity in terms of complications Apart from anemia, iron deficiency is common and constitutes a factor of poor prognosis in diseases chronic, all pathologies very frequently found in the elderly. It is the origin of the deterioration in the general condition of patients, their re-hospitalization or even the progression of their pathology. In this context where elderly patients also present a certain number of comorbidities including the pathologies mentioned previously, it is important to better diagnose the deficiency martial in the elderly patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2022
CompletedFirst Posted
Study publicly available on registry
August 25, 2022
CompletedStudy Start
First participant enrolled
November 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2022
CompletedMarch 28, 2025
March 1, 2025
24 days
August 22, 2022
March 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of patients diagnosed with iron deficiency on inclusion
The diagnosis of iron deficiency will be made from the measurements of the ferritinemia and CST: Ferritinemia \< 100 µg/L and/or CST \< 20%
Day 1
Study Arms (1)
Blood sampling
EXPERIMENTALBlood sampling
Interventions
Eligibility Criteria
You may qualify if:
- Any patient hospitalized in a geriatric unit (short geriatric stay, SSR) or seen on an outpatient basis (hospitalization day, consultation)
- Affiliated patient or beneficiary of a social healthcare system
- Patient having given written consent
You may not qualify if:
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vifor Pharmalead
Study Sites (16)
Chu Angers
Angers, 49933, France
CH de Bayonne
Bayonne, 64100, France
Ch De Calais
Calais, 62107, France
CH Chambéry
Chambéry, 73000, France
CHSF
Corbeil-Essonnes, 91100, France
Ch de Dunkerque
Dunkirk, 59385, France
Hôpital Gériatrique Les Bateliers Chu Lille
Lille, 59037, France
Chu De Nantes, Hôpital Bellier
Nantes, France, France
CHU de NICE-hopital CIMIEZ
Nice, 6003, France
Hopital Saint Antoine
Paris, 75571, France
CH de Pau
Pau, 64000, France
CHU de Poitiers
Poitiers, 86021, France
HUS - Hôpitaux Universitaires de Starsbourg
Strasbourg, 67000, France
Hôpital Bretonneau
Tours, 37044, France
Chu Nancy
Vandœuvre-lès-Nancy, 54511, France
HCL
Villeurbanne, 69100, France
Related Publications (1)
Fougere B, Puisieux F, Chevalet P, Annweiler C, Michel E, Joly L, Blanc F, Azouzi AE, Desre-Follet V, Cacoub P; CARENFER PA study group*. Prevalence of iron deficiency in patients admitted to a geriatric unit: a multicenter cross-sectional study. BMC Geriatr. 2024 Jan 30;24(1):112. doi: 10.1186/s12877-024-04719-6.
PMID: 38287253DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2022
First Posted
August 25, 2022
Study Start
November 15, 2022
Primary Completion
December 9, 2022
Study Completion
December 9, 2022
Last Updated
March 28, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share